Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

NCT05804734 is registered in ClinicalTrials.gov with Groupe Maladies hémorragiques de Bretagne as lead sponsor.

NCT NCT05804734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05804734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia
Lead sponsor
Groupe Maladies hémorragiques de Bretagne
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
December 31, 2021
Enrollment
54 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, hemophilia a, hemophilia b